AN2 Therapeutics, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Operating income | -$38.1 | -$56.8 | -$69.6 | -$42.3 | -$21.6 |
| Net income | -$35.2 | -$51.3 | -$64.7 | -$41.0 | -$21.5 |
Shares outstanding 37.7M · Free float 64.3%
Annual filing data through FY ended December 31, 2025; float as of October 6, 2026.